FDA Inspection 806735 — University of Pittsburgh Cancer Institute Cancer Service

University of Pittsburgh Cancer Institute Cancer Service — FEI 3000203655

The FDA completed an inspection of University of Pittsburgh Cancer Institute Cancer Service on November 9, 2012 in Erie, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 9, 2012
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Erie, PA (United States)